Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 266Neoplasms 231Carcinoma, Non-Small-Cell Lung 209Colorectal Neoplasms 155Prostatic Neoplasms 148Lung Neoplasms 121Neoplasm Metastasis 112Ovarian Neoplasms 105Multiple Myeloma 98Pancreatic Neoplasms 91Leukemia, Myeloid, Acute 82Squamous Cell Carcinoma of Head and Neck 76Endometrial Neoplasms 67Melanoma 66Stomach Neoplasms 63Glioblastoma 61Recurrence 58Brain Neoplasms 56Carcinoma, Hepatocellular 53Urinary Bladder Neoplasms 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Head and Neck Neoplasms 51Carcinoma, Renal Cell 51Triple Negative Breast Neoplasms 50Lymphoma 50Hematologic Neoplasms 47Glioma 46Esophageal Neoplasms 46Colonic Neoplasms 46Small Cell Lung Carcinoma 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Infectious Mononucleosis × 30 days × Clear all
NCT00032513 2026-06-01

Genetic Studies of Chronic Active Epstein-Barr Disease

National Institutes of Health Clinical Center (CC)

Recruiting
300 enrolled
Lymphoid

Herpes Simplex, Infectious Mononucleosis, Lymphoproliferative Disorders, Virus Diseases, Epstein-Barr Virus Infections

NCT06908096 2026-05-18

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
750 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡